Ohio State Navbar

Directory

Susan L. Koletar, MD, FACP


Staff photo

410 W 10th Ave
Columbus, OH 43210

Phone: (614) 293-8732

Email: koletar.1@osu.edu

 

Current OSU Appointments

Professor-Clinical, Infectious Diseases

Physician, FGP-Infectious Diseases

 

Certifications

1984 - present Medical Boards: National Board of Medical Examiners
1987 - present Board Certified: American Board of Internal Medicine
1988 - present Board Certified: American Board of Internal Medicine
1984 - 1998 Stste Medical License: West Virginia Board of Medicine
2006 - 2008 State Medical License: State Medical Board of Ohio
 

Chapters in Books

Koletar SL, Para MF. "Mitral Valve Prolapse and Infective Endocarditis." In Mitral Valve Prolapse and The Mitral Valve Prolapse Sndrome. Edited by Wooley & Boudoulas. 275-288. Mount Kisco, NY, US|USA: Futura Publishing Co., June 1988.

Para MF, Koletar SL. "Immunization." In Infection, Resistance, and Immunity. Edited by Kreier JP and RF Mortensen. -. New York, NY, US|USA: Harper and Row, June 1990.

Koletar SL. "Concepts in Antimicrobial Therapy: Antimicrobial Mechanisms of Action.." In Textbook of Diagnostic Microbiology. Edited by Manuselis G and CR Mahon. -. Philadelphia, PA, US|USA: W.B. Saunders, Co., January 1995.

Koletar SL. "Mitral Valve Prolapse and Infective Endocarditis." In Mitral Valve: Floppy Mitral Valve, Mitral Valve Prolapse, and Mitral Valvular Regurgitation. Edited by Boudoulas and Wooley. -. Armonk, NY, US|USA: Futura Publishing Co., Inc., January 2000.

Koletar SL. "Concepts in Antimicrobial Therapy: Antimicrobial Mechanisms of Action." In Textbook of Diagnostic Microbiology. Edited by CR Mahon and Manuselis G. -. Philadelphia, PA, US|USA: W/B. Saunders, Co., January 2000.

Keeling TC, Koletar SL. "Meningitis, Acute Bacterial." In The 5-Minute Neurology Consult. Edited by Lynn DJ, Newton HB, Rae. -. Philadelphia, PA, US|USA: Lippincott Williams & Wilkins, January 2004.

Keeling TC, Koletar SL. "Meningitis, Aseptic." In The 5-Minute Neurology Consult. Edited by Lynn DJ, Newton HB, Rae-Grant AD. -. Philadelphia, PA, US|USA: Lippincott Williams & Wilkins, January 2004.

Keeling TC, Koletar SL. "Encephalitis." In The 5-Minute Neurology Consult. Edited by Lynn DJ, Newton HB, Rae-Grant AD. -. Philadelphia, PA, US|USA: Lippincott Williams & Wilkins, January 2004.

Bacterial Meningitis. "Sarvepalli SK, Koletar SL." In The 5-Minute Neurology Consult. Edited by Lynn DJ, Newton H, Rae-Grant A.. -. Philadelphia, PA, US|USA: Lippincott, Williams and Wilkins, June 2012.

 

Conferences

Joy,U; Poi,M; Hughes,L; Brady,M,T; Koletar,S,L; Para,M,F; Fan-Havard,P. "Third-trimester maternal toxicity with nevirapine use in pregnancy." In OBSTETRICS AND GYNECOLOGY. (November 2005). 1032-1038.

 

Degrees

1979 B.A., West Virginia University

1983 M.D., West Virginia University

1986 None Indicated, West Virginia University

1988 None Indicated, Ohio State University College of Medicine

 

Editorial Activities

present International Journal of STD & AIDS
present HIV Medicine
present Clinical Infectious Diseases
present AIDS Research and Human Retroviruses
present Journal of Antimicrobial Chemotherapy
present Infectious Diseases in Clinical Practice
1995 - 2001 Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics
 

Honors

0 Phi Beta Kapa.
1986 Internal Medicine Teaching Award. Department of Internal Medicine.
1993 College of Medicine Faculty Teaching Award. College of Medicine.
1994 College of Medicine Faculty Teaching Award. College of Medicine.
1995 College of Medicine Professor of the Year. College of Medicine.
2002 Master Teacher Award. American College of Physicians - American Society of Internal Medicine (Ohio Chapter).
2005 - 2006 America's Best Doctors. US news and World Report.
2007 - 2008 America's Best Doctors. U.S. News & World Report.
2008 - 2009 America's Best Doctors. U.S. News & World Report.
2009 - 2010 America's Best Doctors. U.S. News & World Report.
2010 - 2011 America's Best Doctors. U.S. News & World Report.
2011 - 2012 America's Best Doctors. U.S. News & World Report.
2012 - 2013 America's Best Doctors. U.S. News & World Report.
 

Journal Articles

HAINES,D,E; Koletar,S,L. "TOPOGRAPHY OF CEREBELLAR CORTICONUCLEAR FIBERS OF THE ALBINO-RAT - VERMIS OF ANTERIOR AND POSTERIOR LOBES." BRAIN BEHAVIOR AND EVOLUTION. Vol. 16, no. 4. (January 1979.): 271-292.

Chambers,R,B; Derick,R,J; Davidorf,F,H; Koletar,S,L; DANGEL,M,E. "VARICELLA-ZOSTER RETINITIS IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTION." ARCHIVES OF OPHTHALMOLOGY. Vol. 107, no. 7. (July 1989.): 960-961.

Koletar,S,L; Russell,J,A; Fass,R,J; Plouffe,J,F. "COMPARISON OF ORAL FLUCONAZOLE AND CLOTRIMAZOLE TROCHES AS TREATMENT FOR ORAL CANDIDIASIS IN PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS." ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. Vol. 34, no. 11. (November 1990.): 2267-2268.

IKERD,T,R; Koletar,S,L. "INVITRO ACTIVITY OF CIPROFLOXACIN, TEMAFLOXACIN, AZITHROMYCIN, CLARITHROMYCIN AND METRONIDAZOLE AGAINST GIARDIA-LAMBLIA." JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. Vol. 31, no. 4. (April 1993.): 615-617.

Cahill,K,V; Hogan,C,D; Koletar,S,L; GERSMAN,M. "INTRAORBITAL INJECTION OF AMPHOTERICIN-B FOR PALLIATIVE TREATMENT OF ASPERGILLUS ORBITAL ABSCESS." OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY. Vol. 10, no. 4. (December 1994.): 276-277.

Powderly, W, G; Finkelstein, D; Feinberg, J; Frame, P; He, W; van der Horst, C; Koletar, S, L; Eyster, M, E; Carey, J; Waskin, H. "A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group.." The New England journal of medicine. Vol. 332, no. 11. (January 1995.): 700-5.

Goff,D,A; Koletar,S,L; BUESCHING,W,J; Barnishan,J; Fass,R,J. "ISOLATION OF FLUCONAZOLE-RESISTANT CANDIDA-ALBICANS FROM HUMAN IMMUNODEFICIENCY VIRUS-NEGATIVE PATIENTS NEVER TREATED WITH AZOLES." CLINICAL INFECTIOUS DISEASES. Vol. 20, no. 1. (January 1995.): 77-83.

Mabee, C, L; Mabee, S, W; Kirkpatrick, R, B; Koletar, S L. "Cirrhosis: a risk factor for cryptococcal peritonitis.." The American journal of gastroenterology. Vol. 90, no. 11. (January 1995.): 2042-5.

Koletar,S,L; OGRADY,N,P; Para,M,F; Fass,R,J. "CLUSTER OF HISTOPLASMOSIS CASES IN PRISONERS WITH HIV-INFECTION." INFECTIOUS DISEASES IN CLINICAL PRACTICE. Vol. 4, no. 6. (November 1995.): 466-468.

Plouffe JF, Baird I, Barnishan J, PorterfieldBaxa J, Best M, Dalieh S, Emerick J, Fass RJ, Gianakopoulos G, Hackman BA, Hadley S, Herbert M, Koletar SL, Maher W, Minor JA, Oglevee BA, Para MF, Parsons J, Rogers T, ScottTibbs G, Tumbleson CS. "Levofloxacin in vitro activities bacteremic isolates of Streptococcus pneumoniae." Diagn Microbiol Infect Dis. Vol. 25, no. 1. (January 1996.): 43-45.

Koch, C, A; Mabee, C, L; Robyn, J, A; Koletar, S, L; Metz, E N. "Exposure to domestic cats: risk factor for Pasteurella multocida peritonitis in liver cirrhosis?." The American journal of gastroenterology. Vol. 91, no. 7. (January 1996.): 1447-9.

Plouffe JF, Herbert MT, File TM, Baird I, Parsons JN, Kahn JB, RiellyGauvin KT, Best M, Dalieh S, Fass RJ, Francis S, Gray G, Hackman BA, Koletar SL, Maher WE, Mazur C, Minor J, Oglevee BA, Para MF, PorterfieldBaxa J,Rogers T, Saltrom SJ, Sarokis M, Scott. "Ofloxacin versus standard therapy in treatment of community-acquired pneumonia requiring hospitalization.." Antimicrob Agents Chemotherapy. Vol. 40, no. 5. (May 1996.): 175-179.

Murray, P, A; Koletar, S, L; Mallegol, I; Wu, J; Moskovitz, B L. "Itraconazole oral solution versus clotrimazole troches for the treatment of oropharyngeal candidiasis in immunocompromised patients.." Clinical therapeutics. Vol. 19, no. 3. (January 1997.): 471-80.

Koletar SL. "Treatment of Mycobacterium avium in Human Immunodeficiency Virus-Infected Individuals." Am J Med. Vol. 19, no. 3. (January 1997.): 471-480.

Wheat,J; MaWhinney,S; Hafner,R; McKinsey,D; Chen,D,F; Korzun,A; Shakan,K,J; Johnson,P; Hamill,R; Bamberger,D; Pappas,P; Stansell,J; Koletar,S; Squires,K; Larsen,R,A; Cheung,T; Hyslop,N; Lai,K,K; Schneider,D; KAUFFMAN,C; Saag,M; Dismukes,W; Powderly,W. "Treatment of histoplasmosis with fluconazole in patients with acquired immunodeficiency syndrome." AMERICAN JOURNAL OF MEDICINE. Vol. 103, no. 3. (September 1997.): 223-232.

Koletar, S, L; Berry, A, J; Cynamon, M, H; Jacobson, J; Currier, J, S; MacGregor, R, R; Dunne, M, W; Williams, D J. "Azithromycin as treatment for disseminated Mycobacterium avium complex in AIDS patients.." Antimicrobial agents and chemotherapy. Vol. 43, no. 12. (January 1999.): 2869-72.

Currier, J, S; Williams, P, L; Koletar, S, L; Cohn, S, E; Murphy, R, L; Heald, A, E; Hafner, R; Bassily, E, L; Lederman, H, M; Knirsch, C; Benson, C, A; Valdez, H; Aberg, J, A; McCutchan, J A. "Discontinuation of Mycobacterium avium complex prophylaxis in patients with antiretroviral therapy-induced increases in CD4+ cell count. A randomized, double-blind, placebo-controlled trial. AIDS Clinical Trials Group 362 Study Team.." Annals of internal medicine. Vol. 133, no. 7. (January 2000.): 493-503.

Fichtenbaum, C, J; Koletar, S; Yiannoutsos, C; Holland, F; Pottage, J; Cohn, S, E; Walawander, A; Frame, P; Feinberg, J; Saag, M; Van der Horst, C; Powderly, W G. "Refractory mucosal candidiasis in advanced human immunodeficiency virus infection.." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. Vol. 30, no. 5. (January 2000.): 749-56.

von Reyn, C, F; Williams, P, L; Lederman, H, M; McCutchan, J, A; Koletar, S, L; Murphy, R, L; Cohn, S, E; Evans, T; Heald, A, E; Colquhoun, D; Bassily, E, L; Currier, J S. "Skin test reactivity and cellular immune responses to Mycobacterium avium sensitin in AIDS patients at risk for disseminated M. avium infection.." Clinical and diagnostic laboratory immunology. Vol. 8, no. 6. (January 2001.): 1277-8.

Neidig, J, L; Koletar, S L. "Safety reporting in clinical trials.." JAMA : the journal of the American Medical Association. Vol. 285, no. 16. (January 2001.): 2077-8.

Koletar, S, L; Heald, A, E; Finkelstein, D; Hafner, R; Currier, J, S; McCutchan, J, A; Vallee, M; Torriani, F, J; Powderly, W, G; Fass, R, J; Murphy, R, L; Murphy, R L. "A prospective study of discontinuing primary and secondary Pneumocystis carinii pneumonia prophylaxis after CD4 cell count increase to > 200 x 106 /l.." AIDS. Vol. 15, no. 12. (January 2001.): 1509-15.

Haberland-Carrodeguas, Christel; Allen, Carl, M; Beck, F Michael; Buesching, William, J; Koletar, Susan, L; Sundstrom, Paula. "Prevalence of fluconazole-resistant strains of Candida albicans in otherwise healthy outpatients.." Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology. Vol. 31, no. 2. (January 2002.): 99-105.

Aberg, Judith, A; Chin-Hong, Peter, V; McCutchan, Allen; Koletar, Susan, L; Currier, Judith S. "Localized osteomyelitis due to Mycobacterium avium complex in patients with Human Immunodeficiency Virus receiving highly active antiretroviral therapy.." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. Vol. 35, no. 1. (January 2002.): E8-E13.

Lederman, Howard, M; Williams, Paige, L; Wu, Julia, W; Evans, Thomas, G; Cohn, Susan, E; McCutchan, J Allen; Koletar, Susan, L; Hafner, Richard; Connick, Elizabeth; Valentine, Fred, T; McElrath, M Juliana; Roberts, Norbert J Jr; Currier, Judith, S; Currier, Judith S. "Incomplete immune reconstitution after initiation of highly active antiretroviral therapy in human immunodeficiency virus-infected patients with severe CD4+ cell depletion.." The Journal of infectious diseases. Vol. 188, no. 12. (January 2003.): 1794-803.

de Boer, Alberdina, W; Markowitz, Norman; Lane, H Clifford; Saravolatz, Louis, D; Koletar, Susan, L; Donabedian, Haig; Yoshizawa, Carl; Duliege, Anne-Marie; Fyfe, Gwendolyn; Mitsuyasu, Ronald T. "A randomized controlled trial evaluating the efficacy and safety of intermittent 3-, 4-, and 5-day cycles of intravenous recombinant human interleukin-2 combined with antiretroviral therapy (ART) versus ART alone in HIV-seropositive patients with." Clin Immunol. Vol. 106, no. 3. (January 2003.): 188-96.

Koletar, Susan, L; Williams, Paige, L; Wu, Julia; McCutchan, J Allen; Cohn, Susan, E; Murphy, Robert, L; Lederman, Howard, M; Currier, Judith, S; Currier, Judith S. "Long-term follow-up of HIV-infected individuals who have significant increases in CD4+ cell counts during antiretroviral therapy.." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. Vol. 39, no. 10. (January 2004.): 1500-6.

Goldman,Mitchell; Zackin,Robert; Fichtenbaum,Carl,J; Skiest,Daniel,J; Koletar,Susan,L; Hafner,Richard; Wheat,L,Joseph; Nyangweso,Peter,M; Yiannoutsos,Constantin,T; Schnizlein-Bick,Carol,T; Owens,Susan; Aberg,Judith,A. "Safety of discontinuation of maintenance therapy for disseminated histoplasmosis after immunologic response to antiretroviral therapy.." Clinical infectious diseases. Vol. 38, no. 10. (May 2004.): 1485-1489.

Goldman,M; Zackin,R; Fichtenbaum,C,J; Skiest,D,J; Koletar,S,L; Hafner,R; Wheat,L,J; Nyangweso,P,M; Yiannoutsos,C,T; Schnizlein-Bick,C,T; Owens,S; Aberg,J,A. "Safety of discontinuation of maintenance therapy for disseminated histoplasmosis after immunologic response to antiretroviral therapy." CLINICAL INFECTIOUS DISEASES. Vol. 38, no. 10. (May 2004.): 1490-1494.

Wohl, David, A; Pilcher, Christopher, D; Evans, Scott; Revuelta, Manuel; McComsey, Grace; Yang, Yijun; Zackin, Robert; Alston, Beverly; Welch, Stacey; Basar, Michael; Kashuba, Angela; Kondo, Pualani; Martinez, Ana; Giardini, Jeffrey; Quinn, Joseph; Littles, Melvin; Wingfield, Harry; Koletar, Susan, L; Koletar, Susan L. "Absence of sustained hyperlactatemia in HIV-infected patients with risk factors for mitochondrial toxicity.." Journal of acquired immune deficiency syndromes. Vol. 35, no. 3. (January 2004.): 274-8.

Joy, Saju; Poi, Ming; Hughes, Laura; Brady, Michael, T; Koletar, Susan, L; Para, Michael, F; Fan-Havard, Patty. "Third-trimester maternal toxicity with nevirapine use in pregnancy.." Obstetrics and gynecology. Vol. 106, no. 5 Pt 1. (January 2005.): 1032-8.

MacGregor, Rob Roy; Hafner, Richard; Wu, Julia, W; Murphy, Robert, L; Perlman, David, C; Bermudez, Luiz, E; Inderlied, Clark, B; Picker, Louis, J; Wallis, Robert, S; Andersen, Janet, W; Mahon, Laura, F; Koletar, Susan, L; Peterson, Dolores, M; Peterson, Dolores M. "Clinical, microbiological, and immunological characteristics in HIV-infected subjects at risk for disseminated Mycobacterium avium complex disease: an AACTG study.." AIDS research and human retroviruses. Vol. 21, no. 8. (January 2005.): 689-95.

Koletar,S,L; Williams,P,L; Wu,J; McCutchan,J,A; Cohn,S,E; Murphy,R,L; Lederman,H,M; Currier,J,S. "How infrequent are opportunistic diseases and immune reconstitution syndromes among HIV-infected individuals who have favorable CD4(+) cell count responses to antiretroviral therapy? Reply." CLINICAL INFECTIOUS DISEASES. Vol. 40, no. 9. (May 2005.): 1380-1381.

Koletar SL, Williams P., Wu J, McCutchan JA, Cohn SE , Murphy RL , Lederman HM, Currier JS. "Reply to Philips – Letter to the Editor." Clin Infect Dis. Vol. 40, no. 9. (May 2005.): 1380-1381.

Gulick, Roy, M; Ribaudo, Heather, J; Shikuma, Cecilia, M; Lalama, Christina; Schackman, Bruce, R; Meyer, William A 3rd; Acosta, Edward, P; Schouten, Jeffrey; Squires, Kathleen, E; Pilcher, Christopher, D; Murphy, Robert, L; Koletar, Susan, L; Carlson, Margrit; Reichman, Richard, C; Bastow, Barbara; Klingman, Karin, L; Kuritzkes, Daniel, R; Kuritzkes, Daniel R. "Three- vs four-drug antiretroviral regimens for the initial treatment of HIV-1 infection: a randomized controlled trial.." JAMA : the journal of the American Medical Association. Vol. 296, no. 7. (January 2006.): 769-81.

Acosta, Edward, P; Kendall, Michelle, A; Gerber, John, G; Alston-Smith, Beverly; Koletar, Susan, L; Zolopa, Andrew, R; Agarwala, Sangeeta; Child, Michael; Bertz, Richard; Hosey, Lara; Haas, David W. "Effect of concomitantly administered rifampin on the pharmacokinetics and safety of atazanavir administered twice daily.." Antimicrobial agents and chemotherapy. Vol. 51, no. 9. (January 2007.): 3104-3110.

Mulligan, Kathleen; Yang, Yang; Wininger, David, A; Koletar, Susan, L; Parker, Robert, A; Alston-Smith, Beverly, L; Schouten, Jeffrey, T; Fielding, Roger, A; Basar, Michael, T; Grinspoon, Steven. "Effects of metformin and rosiglitazone in HIV-infected patients with hyperinsulinemia and elevated waist/hip ratio.." AIDS (London, England). Vol. 21, no. 1. (January 2007.): 47-57.

McCutchan, J Allen; Wu, Julia, W; Robertson, Kevin; Koletar, Susan, L; Ellis, Ronald, J; Cohn, Susan; Taylor, Michael; Woods, Steven; Heaton, Robert; Currier, Judith; Williams, Paige L. "HIV suppression by HAART preserves cognitive function in advanced, immune-reconstituted AIDS patients.." AIDS (London, England). Vol. 21, no. 9. (January 2007.): 1109-1117.

Kuritzkes, Daniel, R; Ribaudo, Heather, J; Squires, Kathleen, E; Koletar, Susan, L; Santana, Jorge; Riddler, Sharon, A; Reichman, Richard; Shikuma, Cecilia; Meyer, William A 3rd; Klingman, Karin, L; Gulick, Roy, M; Gulick, Roy M. "Plasma HIV-1 RNA dynamics in antiretroviral-naive subjects receiving either triple-nucleoside or efavirenz-containing regimens: ACTG A5166s.." The Journal of infectious diseases. Vol. 195, no. 8. (January 2007.): 169-176.

Gulick, Roy, M; Lalama, Christina, M; Ribaudo, Heather, J; Shikuma, Cecilia, M; Schackman, Bruce, R; Schouten, Jeffrey; Squires, Kathleen, E; Koletar, Susan, L; Pilcher, Christopher, D; Reichman, Richard, C; Klingman, Karin, L; Kuritzkes, Daniel R. "Intensification of a triple-nucleoside regimen with tenofovir or efavirenz in HIV-1-infected patients with virological suppression.." AIDS (London, England). Vol. 21, no. 7. (January 2007.): -.

Young JD, Mangino JE, Stevenson KB, and Koletar SL. "Nitazoxanide versus metronidazole for Clostridium difficile colitis.." Clin Infect Dis. Vol. 44, no. 1. (January 2007.): 152-.

Sattler FR, Rajicic N, Mulligan K, Yarasheski K, Koletar SL, Zolopa A, Alston-Smith B, Zackin R, Bistrian Bfor the ACTG 392 Team. "Evaluation of High Protein Supplementation in HIV Positive Subjects with Stable Weight Loss: a Randomized, Double-Blind, Multicenter Trial." American Journal Clinical Nutrition. Vol. 88, (January 2008.): 313-321.

Smurzynski M, Collier AC, Koletar SL, Bosch RJ, Wu K, Bastow B, Benson CA.. "AIDS Clinical Trials Group Longitudinal Linked Randomized Trials (ALLRT): Rationale, Design, and Baseline Characteristics.." HIV Clin Trials. Vol. 9, no. 4. (July 2008.): 269-282.

Gupta SK, Rosenkranz SL, Cramer YS, Koletar SL, Szczech LA, Amorosa V, Hall SD.. "The Pharmacokinetics and Pharmacogenomics of Efavirenz and Lopinavir/Ritonavir in HIV-Infected Persons Requiring Hemodialysis.." AIDS. Vol. 22, (January 2008.): 1919-1927.

Sax, PE, Tierney, C., Collier, AC, Fischl, MA, Mollan, K, Peeples, L., Godfrey, C, Jahed, NC, Myers, L., Katzenstein, D, Farajallah, A, Rooney, JF, Ha, B, Woodward, WC, Koletar, SL, Johnson, VA, Geiseler, PJ, Daar, ES for the AIDS Clinical Trials Group Study A5202 Team. "Tenofovir Disoproxil Fumarate/Emtricitabine versus Abacavir/Lamivudine as Part of Once-Daily Regimens for Initial Treatment of HIV-1 Infection." N Eng J Med. Vol. 23, no. 361. (July 2009.): 2230-2240.

Sax,Paul,E; Tierney,Camlin; Collier,Ann,C; Fischl,Margaret,A; Mollan,Katie; Peeples,Lynne; Godfrey,Catherine; Jahed,Nasreen,C; Myers,Laurie; Katzenstein,David; Farajallah,Awny; Rooney,James,F; Ha,Belinda; Woodward,William,C; Koletar,Susan,L; Johnson,Victoria,A; Geiseler,P,Jan; Daar,Eric,S. "Abacavir-Lamivudine versus Tenofovir-Emtricitabine for Initial HIV-1 Therapy." NEW ENGLAND JOURNAL OF MEDICINE. Vol. 361, no. 23. (December 2009.): 2230-2240.

Chow D, Chen H, Glesby MJ, Busti A, Souza S, Andersen J, Kohrs S, Wu J, Koletar SL. "Short-term ezetimibe is well tolerated and effective in combination with statin therapy to treat elevated LDL cholesterol in HIV-infected participants." AIDS. Vol. 23, (January 2009.): 2133-2141.

Williams PL, Wu J, Cohn SE, Koletar SL, McCutchan JA, Murphy RL, and Currier JS for the AIDS Clinical Trials Group 362 Study Team. "Improvement in Lipid Profiles Over 6 Years of Follow-up in Adults with AIDS and Immune Reconstitution." HIV Med. Vol. 10, no. 5. (January 2009.): 290-301.

Haas DW, Koletar SL, Laughlin L, Kendall MA, Suckow C, Gerber JG, Zolopa AR, Bertz R, Child MJ, Acosta EP for the A5213 Study Team. "Hepatotoxicity and Gastrointestinal Intolerance when Healthy Volunteers taking Rifampin add Twice-Daily Atazanavir and Ritonavir." J Acquir Immune Deficicney Syndrome. Vol. 50, (January 2009.): 290-293.

Gupta, SK, Komarow L, Gulick RM, Pollard RB, Robbins GK, Franceschini N, Szczech LA, Koletar SL, Kalayjian RC.. "Proteinuria, Creatinine Clearance, and Immune Activation in Antiretroviral-Naïve HIV-Infected Subjects." J Inf Dis. Vol. 200, (January 2009.): 614-618.

Smurzynski M, Wu K, Benson CA, Bosch RJ, Collier AC, Koletar SL. "Relationship between CD4+ T-cell counts/HIV-1 RNA plasma viral load and AIDS defining events among persons followed in the ACTG Longitudinal Linked Randomized Trials (ALLRT) study.." J Acquir Immune Defic Syndr. Vol. 1:55, no. (1). (September 2010.): 17-27.

Krishnan S, Wu K, Smurzynski M, Bosch RJ, Benson CA, Collier AC, Klebert MK, Feinberg J, Koletar SL: for the ALLRT/A5001 team.. "Incidence rate of and factors associated with loss-to-follow-up in a longitudinal cohort of anti-retroviral treated HIV-infected persons: an AIDS Clinical Trials Group (ACTG) Longitudinal Linked Randomized Trials (ALLRT) analysis.." HIV Clinical Trials. Vol. 12, no. 4. (January 2011.): 190-200.

Wang D, Para MF, Koletar SL, Sadee W.. "Human N-acetyltransferase 1 *10 and *11 alleles increase protein expression through distinct mechanisms and associate with sulfamethoxazole-induced hypersensitivity." Pharmacogenetics and Genomics. Vol. 21, no. 10. (October 2011.): 652-654.

Krishnan S, Wu K, Smurzynski M, Bosch RJ, Benson CA, Collier AC, Klebert MK, Feinberg J, Koletar SL: for the ALLRT/A5001 team.. "Incidence rate of and factors associated with loss-to-follow-up in a longitudinal cohort of anti-retroviral treated HIV-infected persons: an AIDS Clinical Trials Group (ACTG) Longitudinal Linked Randomized Trials (ALLRT) analysis.." HIV Clinical Trials. Vol. 12, no. 24. (July 2011.): 190-200.

Rahmanian S, Wewers ME, Koletar SL, Reynolds N, Ferketich A, Diaz P.. "Cigarette Smoking in the HIV- Infected Population.." Proc Am Thorac Soc. Vol. 8, no. 3. (June 2011.): 313-319.

Ribaudo HJ, Benson CA, Zheng Y, Koletar SL, Collier AC, Lok JJ, Smurzynski M, Bosch RJ, Bastow B, Schouten JT for the ACTG A5001/ALLRT Protocol Team. "No Risk of Myocardial Infarction Associated with Initial Antiretroviral Treatment Containing Abacavir: Short and Long-Term Results from ACTG A5001/ALLRT." Clin Inf Dis. Vol. 52, no. 7. (January 2011.): 929-940.

Krishnan S, Schouten JT, Jacobson DL, Benson CA, Collier AC, Koletar SL, Santana J, Sattler FR, Mitsuyasu R, for the ACTG-ALLRT protocol team. "Incidence of Non-AIDS Defining Cancer (NADC) in Anti-Retroviral Treatment (ART) Naïve Subjects After ART Initiation: An ALLRT (ACTG Longitudinal Linked Randomized Trials) Analysis.." Oncology. Vol. 80, (January 2011.): 42-49.

Wang D, Para MF, Koletar SL, Sadee W.. "Human N-acetyltransferase 1 *10 and *11 alleles increaseprotein expression through distinct mechanisms and associate with sulfamethoxazole-induced hypersensitivity.." Pharmacogenetics and Genomics. Vol. 21, no. 10. (January 2011.): 652-664.

Cohn SE, Jiang H, McCutchan JA, Koletar SL, Murphy RL, Robertson KR, Destmaurice A, Currier JS, Williams PL. "Association of Ongoing Drug and Alcohol Use with Non-Adherence to Antiretroviral Therapy and Higher Risk of AIDS and Death: Results from ACTG 362." AIDS Care. Vol. 1_11 iFirst, (January 2011.): 775-785.

Kynyk JA, Parsons JP, Para MF, Koletar SL, Diaz PT, Mastronarde JG. "HIV and Asthma, Is There an Association?." Respir Med.. Vol. 106, no. 4. (April 2012.): 493-494.

Wang,Danxin; Curtis,Amanda; Papp,Audrey,C; Koletar,Susan,L; Para,Michael,F. "Polymorphism in glutamate cysteine ligase catalytic subunit (GCLC) is associated with sulfamethoxazole-induced hypersensitivity in HIV/AIDS patients." BMC MEDICAL GENOMICS. Vol. 5, (July 2012.): 32-.

Bakker RG, Koletar SL, Bazan JA. "Infections of the Central Nervous System due to Nutritionally Variant Streptococci: Report of Four Cases and Review of the Literature.." Infectious Diseases in Clinical Practice. Vol. 20, no. 1. (January 2012.): 28-31.

Ferketich AK, Diaz P, Browning KK, Lu B, Koletar SL, Reynolds NR, Wewers ME. "Safety of Varenicline Among Smokers Enrolled in the Lung HIV Study.." Nicotine & Tobacco Research. Vol. *, no. *. (May 2012.): Epub ahead of print-.

Yanik,Elizabeth,L; Napravnik,Sonia; Ryscavage,Patrick; Eron,Joseph,J; Koletar,Susan,L; Moore,Richard,D; Zinski,Anne; Cole,Stephen,R; Hunt,Peter; Crane,Heidi,M; Kahn,James; Mathews,William,C; Mayer,Kenneth,H; Taiwo,Babafemi,O. "Hematologic, Hepatic, Renal, and Lipid Laboratory Monitoring After Initiation of Combination Antiretroviral Therapy in the United States, 2000-2010." JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES. Vol. 63, no. 2. (June 2013.): 216-220.

Kynyk JA, Parsons JP, Para MF, Koletar SL, Diaz PT. "HIV and Asthma, Is There an Association?." Respiratory Medicine. -.

 

Reference Works

October 1985 Koletar SL, Georgiev MT and RF Hoy."The Effect of Low-Dose Aspirin on Serum Lipids" Morgantown.
October 1988 Fass RJ and SL Koletar."Treatment of Severe Gram-Negative Osteomyelitis with Oral Ciprofloxacin." Los Angelas.
September 1989 Koletar SL, Russell JA, Fass RJ, and JF Plouffe."A Comparison of Fluconazole with Clotrimazole Troches as Treatment for Oropharyngeal Thrush in Patients with HIV Infection" Houston.
October 1990 Pons VG, Greenspan D, Koletar SL, DeBruin MF, and the Multicenter Study Group."Comparative Study of Fluconazole and Clotrimazole Troches for the Treatment of Oral Thrush in AIDS" Atlanta.
October 1992 Koletar SL, O’Grady NP, and MF Para."A Cluster of Cases of Disseminated Histoplasmosis in HIV-infected Prisoners" Anaheim.
June 1993 Koletar SL, and NP O’Grady."Treatment of Disseminated Histoplasmosis" Berlin.
December 1993 Koletar SL, Weed HG, and MB Ramundo."Thrush Unresponsive to Treatment with Fluconazole in HIV-infected Patients" Washington.
December 1993 Berry A, Koletar SL, and D Williams."Azithromycin Therapy for Disseminated Mycobacterium avium-intracellulare in AIDS Patients" Washington.
January 1994 Koletar SL, Williams D, and A Berry."Serum Level and MIC do not Correlate with the Efficacy of Azithromycin for Disseminated Mycobacterium avium-complex (MAC) Infection in Patients with AIDS" Venice.
October 1994 Ramundo MB, and SL Koletar."Invasive Aspergillus Infections in AIDS Patients" Orlando.
October 1994 Koletar SL."Azithromycin Improves Survival in AIDS Patients with Disseminated Mycobacterium avium-complex (MAC)." Orlando.
November 1994 Mabee CL, Mabee SW, and SL Koletar."Hepatic Dysfunction: A Risk Factor for Cryptococcal Peritonitis" Columbus.
September 1995 Koletar SL, Buesching WJ, and RJ Fass."Emerging Resistance to Fluconazole Among Blood and CSF Cryptococcus neoformans Isolates" San Francisco.
September 1995 Fichtenbaum C, Koletar S, Yiannoutsos C, Chen D, Pottage J, Kobayshi G, Powderly W, for the ACTG 816 Team."Predictors of Fluconazole Resistant Candida in Advanced HIV Infection" San Francisco.
November 1995 Murry A and SL Koletar."Listerial Infections: An Exploration of Presentation, Treatment, and Future Directions" Columbus.
November 1995 Koch CA, Mabee CL, Robyn JA, Koletar SL and EN Metz."Exposure to Domestic Cats: Risk Factor for Pasteurella multocida Peritonitis in Liver Cirrhosis and Squamous Cell Cancer of the Head and Neck?" Columbus.
July 1996 Fichtenbaum C, Koletar S, Yiannoutsos C, Chen D, Cohn S, Pottage J, Kobayshi G, Powderly W, for the ACTG 816 Team."Fluconazole Resistant Mucosal Candidiasis in Advanced HIV Infection" vancouver.
September 1996 Saravolatz L, Mitsuyasu R, Sneller M, MacArthur RD, Koletar SL, Markovitz N, Donabedian H, Lane HC, Fyfe G.."Duration of Proleukin IL-2 Therapy Is More Important Than Total Dose in Achieving CD4 Expansion" New orleans.
September 1996 Murry AR, Jackson BM, Maher WE, and SL Koletar."Burkholderia cepacia: An Emerging Pathogen" .
September 1996 Koletar, SL and JA Russell."Characteristics of Patients >50 Years of Age with Newly Diagnosed HIV Infection" .
May 1998 Koletar SL."Opportunistic Infections in AIDS Patients" Nice.
May 1998 Haberland C, Allen C, Beck M, Buesching W, Koletar S, Sundstrom P."Prevalence of fluconazole resistant strains of Candida sp. in outpatients" Dallas.
February 1999 Fichtenbaum C, Ignatov A, Mersman D, Keath E, Koletar S, Powderly W for the ACTG 816 Team."The Molecular Epidemiology of Fluconazole Refractory Oral Candidiasis" Chicago.
September 1999 Keeling TC, Koletar SL."Candida glabrata Urinary Tract Infections in ICU Patients" San Francisco.
September 1999 Currier JS, Williams PL, Koletar SL, Murphy RL, Cohn S, Heald A, Knirsch C, Taylor J, Colqhoun D, Nevin T, Hafner R, McCutchan JA.."A Randomized, Placebo-Controlled Trial of Azithromycin Prophylaxis for the Prevention of Mycobacterium avium Complex (MAC) in Subjects with Increases in CD4 Cells on Antiretroviral Therapy" San Francisco.
April 2000 Murphy R, Andersen J, Peterson D, Koletar SL, Benson C, Hafner R, Perlman D, Bassily E, MacGregor R for the ACTG 341 Team."Sustained Virologic Response to Triple Class Antiretroviral Therapy in HIV-infected Subjects at risk for Mycobacterium avium complex Disease" Chicago.
September 2000 Gastaldo JM, Neidig JL, Para MF, Diaz PT, Koletar SL."The clinical significance of the drug interaction between protease inhibitors and midazolam" Toronto.
October 2000 Janssen W, Koletar SL."Lactic acidosis and hepatic steatosis in a woman with HIV infection" Cincinnati.
February 2000 MacGregor RR, Perlman DC, Murphy R, Inderlied C, Andersen J, Bassily E, Koletar SL, Peterson D, Hafner R and the ACTG341 Study Team."Frequency of Isolation of M. avium complex (MAC) from Marrow in Patients Suspected of Disseminated MAC (DMAC) But With Negative Blood Cultures." San Francisco.
February 2000 Koletar SL, JS Currier, PL Williams, R Hafner, RL Murphy, S Cohn, C Knirsch, T Nevin, and JA McCutchan for the ACTG 362 Team."Prevention of Opportunistic Infections Other than Mycobacterium avium Complex (MAC) in a Randomized, Placebo-Controlled Trial of Azithromycin (AZ) Prophylaxis in Subjects with Increases in CD4 Cells on Antiretroviral Therapy (ART) - Preliminary Results" San Francisco.
February 2000 Koletar SL, AE Heald, RL Murphy, R Hafner, T Nevin, J Taylor and D Finkelstein for the ACTG 888 Team."Discontinuing Primary and Secondary PCP Prophylaxis in Patients Who Have Increased CD4 Counts in Response to Antiretroviral Therapy: Preliminary Results– ACTG 888" San Francisco.
February 2002 Koletar SL, Wu J, McCutchan JA, Williams PL, Murphy RL, Nevin T, and Currier JS for the ACTG 362 Team."Long-term follow-up of HIV-infected individuals who have experienced immune reconstitution following severe immunosuppression" Seattle.
February 2003 Wohl DA, Pilcher CD, Revuelta M, McComsey G, Koletar SL, Evans S, Yijun Y, Zackin R, Alston B, Welch S, Basar M, Kashuba A, Kondo P., Quinn J, and Wingfield H."Absence of Sustained Hyperlactatemia Among HIV-Infected Patients with Risk Factors for Mitochondrial Toxicity" Boston.
September 2003 Goldman M, Zackin R, Fichtenbaum CJ, Wheat LJ, Koletar SL, Skiest DJ, Schnizlein-Bick CT, Hafner R, Nyangweso P, Yiannoutsos C, Andersen JW, Owens S, Hogg E, Aberg JA."Discontinuation of Antifungal Therapy for Disseiminated Histoplasmosis (DH) following Immunologic Response to Antiretroviral Therapy (ART) is Safe: AIDS Clinical Trials Group Study A5038" Chicago.
February 2004 McCutchan JA, Wu J, Williams PL, Robertson K, Ellis R, Koletar SL, Currier JS and the ACTG 362 Study Team."Improved Cognitive Function in Immune Reconstituted Advanced AIDS Patients Is Associated with Maintenance of HIV Suppression" San Francisco.
March 2005 Joy SD, Poi M, Hughes L, Brady MT, Koletar SL, Para MF, Fan-Havard P."Third Trimester Maternal Toxicity with Nevirapine Use in Pregnancy" .
February 2005 Williams P, Wu J, Cohn S, Koletar SL, McCutchan JA, Murphy R, & Currier JS for the ACTG 362 Team."Risk of Cardiovascular Disease (CVD) in HIV-infected Adults with Immune Reconstitution" Boston.
October 2005 Franco A, Joy S, Kang S, Poi M, Hunkler J, Brady M, Koletar S, Para M, Fan-Havard P."Maternal and Newborn Outcomes in a Multidisciplinary HIV Pregnancy Program" San Francisco.
April 2006 Peters J, Franco A, Joy SD, Hunkler J, Brady MT, Koletar SL, Para MF, Lamberjack K, and Fan-Havard, P."Maternal, Newborn, and Placental Outcomes in a Multidisciplinary HIV Pregnancy Program" Columbus.
February 2006 Smurzynski M, Collier AC, Koletar SL, Wu K, Bosch RJ, Benson CA."Opportunistic Infections Occurring after Initiation of Randomized HAART Regimens in Treatment-naïve HIV-1 Infected Patients Followed in the ACTG Longitudinal Linked Randomized Trials (ALLRT) Study" Denver.
February 2006 Gupta S, Rosenkranz SL, Segal Y, Koletar SL, Basar M, Szczech L, Amorosa V, Hall S.."The Steady-state Pharmacokinetics (PK) of Efavirenz (EFV) and Lopinavir/Ritonavir (LPV/RTV) in HIV-infected Persons Requiring Hemodialysis: AIDS Clinical Trials Group Study A5177" Denver.
July 2007 Gupta SK, Komarow L, Gulick RM, Pollard RB, Robbins GK, Franceschini N, Szczech LA, Koletar SL, Kalayjian RC."Proteinuria, Creatinine Clearance, and Immune Activation in HIV-Infected Subjects: A Secondary Analysis of Treatment-Naïve Studies ACTG 384, A5095, and A5001" Sydney.
February 2007 Acosta EP, Kendall MA, Gerber JG, Suckow C, Koletar SL, Zolopa AR, Laughlin L, Agarwala S, Child MJ, Haas DW, for the A5213 Study Team."Effect of Rifampin on Pharmacokinetics and Safety of Twice-Daily Atazanavir: ACTG Protocol A5213" Los Angelas.
March 2008 Ribaudo HJ, Collier AC, Koletar SL, Smurzynski M, Zheng Y, Bosch RJ, Benson CA.."Risk Factors Associated with Serious Non-AIDS-Defining Events (NADE) Following Treatment Initiation in Antiretroviral Naïve Individuals Enrolled in the AIDS Clinical Trials Group (ACTG) Longitudinal Linked Randomized Trials (ALLRT) Study" Malaga.
February 2008 Koletar SL, Smurzynski M, Wu K, Collier AC, BoschRJ, Benson CA."Opportunistic Infections Occurring in Treatment-Experienced HIV-1 Infected Patients Followed in the ACTG Longitudinal Linked Randomized Trials (ALLRT) Study" .
February 2008 Haas DW, Koletar SL, Laughlin L, Kendall MA, Suckow C, Gerber JG, Zolopa AR, Bertz R, Child MJ, Acosta EP for the A5213 Study Team."Hepatic Transaminase Elevations and Gastrointestinal Intolerance when HIV-Negative Healthy Volunteers on Rifampin (RIF) add Twice-Daily Atazanavir (ATV 300 mg)/Ritonavir (RTV 100 mg): ACTG Protocol A5213" Boston.
February 2008 Day SR, Koletar SL, Mangino JE, Stevenson KB, Para MF.."The Effect of Chronic Trimethoprim/sulfamethoxazole (TMP/SMX) Use on Nasal Carriage of Staphylococcus aureus in HIV Infected Patients" Boston.
April 2008 Acree ME, Jason C, Tshiamala M, Koletar SL.."Occupational Stress in Zambian Palliative Care Nurses: Emphasis of Care in a Resource-Limited Setting." New Haven.
April 2009 Cohn SE, Williams PL, Jiang JH, McCutchan JA, Koletar SL, Robertson KR, deStMaurice A, Murphy RL, Currier JS."Ongoing Substance Use Predicts Non-Adherence to Antiretroviral Therapy and Higher Risk of AIDS and Death: Results from ACTG 362" Miami.
April 2009 Cohn SE, Williams PL, Jiang HJ, McCutchan JA, Koletar SL, Robertson KR, deStMaurice A, Murphy RL, Currier JS and ACTG 362 Team."Ongoing Illicit Drug Use Predicts Non-adherence to Antiretroviral Therapy and Higher Risk of AIDS and Death: Results from ACTG 362." Montreal.
February 2009 Chow D, Chen H, Glesby MJ, Busti A, Souza S, Kohrs S, Wu J, Andersen J, Koletar SL."Ezetimibe is Safe and Effective in Combination with Statin Therapy for the Treatment of Elevated LDL Cholesterol in HIV-Infected Subjects: Results of ACTG Protocol A5209" Montreal.
February 2009 Benson CA, Zheng E, Ribaudo H, Koletar SL, Collier A, Smurzynski M, Bosch R, Bastow B, Schouten J for the ACTG A5001/ALLRT Protocol Team."No Association of Abacavir (ABC) Use with Risk of Myocardial Infarction (MI) or Severe Cardiovascular Disease Events (SCVD): Results from ACTG A5001/ALLRT" Montreal.
January 2009 Brawner E, Browning K, Harness J, Reynolds N, Ferketich A, Drake J, Koletar S, Diaz P, Wewers ME.."Smoking Cessation in the HIV Seropositive Population" .
October 2009 Narla R, Martin SI, Koletar, SL."Severe Group A Streptococcus Infections – Presentation, Pathology and Immunotherapy" Columbus.
March 2010 Krishnan S, Wu K, Smurzynski M, Bosch R, Benson CA, Collier AC, Koletar SL for the ALLRT/A5001 team."Incidence rate (IR) and factors associated with loss-to-follow-up (LTFU) in a longitudinal study of HIV-infected subjects receiving antiretrovirals: an AIDS Clinical Trials Group (ACTG) Longitudinal Linked Randomized Trials (ALLRT) analysis" Barcelona.
July 2010 Koletar SL, Hartley D, Bosch R, Patton, L, Pavlov G, Bartlett, JA for the Performance Evaluation Committee of the ACTG.."Performance Evaluation Metrics and Standards Developed by the AIDS Clinical Trials Group (ACTG) Network" .
March 2012 Wohl DA, Arnoczy G, Fichtenbaum C, Campbell T, Taiwo B, Hicks C, McComsey GA, Koletar SL, Sax P, and Stein J.."Cardiovascular Disease (CVD) Risk Markers in Patients Receiving Abacavir, Tenofovir, and Zidovudine: The Nucleoside Inflammation, Coagulation and Endothelial Function (NICE) Study." Seattle.
March 2012 Taiwo B, Yanik E , Napravnik S, Ryscavage P, Koletar SL, Moore R, Kahn J, Matthews CW, Crane H, Eron JJ on behalf of the CFAR Network of Integrated Clinical Systems (CNICS) Cohort Study.."Laboratory Abnormalities Following Initiation of Modern ART in the US, 2000-2010 among the CNICS Cohort." Seattle.

Presentations

"New Beta-Lactam Antibiotics." Presented at Ninth Annual Infectious Diseases Seminar for the Practicing Physician, Cambridge, OH, US|USA. (July 1988)

"Approach to Rational Use of Antibiotics." Presented at Infectious Diseases 1990: Current Problems, Columbus, OH, US|USA. (February 1989)

"Tuberculosis." Presented at Comprehensive Review in Internal Medicine, Newark, OH, US|USA. (August 1989)

"HIV Infection-Management Issues." Presented at Grand Rounds, Columbus, OH, US|USA. (August 1989)

"Common Opportunistic Infections Seen in AIDS Patients." Presented at AIDS: An Allied Health Perspective, Columbus, OH, US|USA. (April 1989)

"Quinolones." Presented at State of West Virginia Annual Family Practice Meeting, Huntington, WV, US|USA. (November 1989)

"HIV Infection-Management After Diagnosis." Presented at Ohio Medical Education Network (OMEN), Columbus, OH, US|USA. (May 1989)

"An Update on Quinolones." Presented at Infectious Diseases - A Seminar for Practicing Health Care Professionals, Charleston, WV, US|USA. (May 1989)

"Current Role of Empiric Antibiotic Therapy." Presented at Grand Rounds, Newark, OH, US|USA. (September 1989)

"Immunizations." Presented at Comprehensive Review in Internal Medicine, Columbus, OH, US|USA. (August 1990)

"New Antifungal Agents." Presented at Toledo Infectious Diseases Society, Monthly Meeting, Columbus, OH, US|USA. (April 1990)

"HIV and Fungus." Presented at Family Practice Grand Rounds, Columbus, OH, US|USA. (December 1990)

"An Update on Quinolones." Presented at Grand Rounds, Fort Wayne, IN, US|USA. (June 1990)

"HIV/AIDS: New Treatments and Therapies." Presented at East Central AIDS Education and Training Centers Teleconference, Columbus, OH, US|USA. (May 1990)

"Antiviral Therapy in Immunocompromised Patients with Chest Problems in the Intensive Care Unit." Presented at West Virginia Thoracic Society Annual Meeting, Silver Creek, WV, US|USA. (January 1991)

"Management of the HIV-Infected Patient." Presented at Infectious Diseases: Current Problems, Columbus, OH, US|USA. (February 1991)

"Management of the HIV-Infected Patient." Presented at Infectious Diseases: Current Problems, Columbus, OH, US|USA. (February 1991)

"AIDS: New and Emerging Treatments." Presented at Ohio Medical Education Network, Columbus, OH, US|USA. (February 1991)

"HIV-Infection: Opportunistic Infections." Presented at Comprehensive Review in Internal Medicine, Columbus, OH, US|USA. (August 1991)

"Fungal Infections in HIV-Positive Patients." Presented at Management of Opportunistic Fungal Infections: Strategies for the 1990's, Dearborn, MI, US|USA. (June 1991)

"Care of the Asymptomatic HIV-infected Patient." Presented at Infectious Diseases: Current Problems, Columbus, OH, US|USA. (February 1992)

"Fungal Infections in HIV-infected Patients." Presented at Family Practice Grand Rounds, Columbus, OH, US|USA. (March 1992)

"Commonly Encountered Infections in the Outpatient Setting." Presented at Ohio Medical Education Network, OMEN, Columbus, OH, US|USA. (March 1992)

"Chronic Fatigue Syndrome - An Update." Presented at Grand Rounds, Lancaster, OH, US|USA. (May 1992)

"Infectious Complications of AIDS." Presented at Grand Rounds, Fort Wayne, IN, US|USA. (July 1992)

"Emergency Management of Infections in the Immunocompromised Host." Presented at Emergency Medicine Rounds, Columbus, OH, US|USA. (August 1992)

"Update on Tuberculosis." Presented at Marshall University Alumni Day Scientific Program, Huntington, WV, US|USA. (September 1993)

"Fungal Infections in HIV-Positive Patients." Presented at OSU, Department of Pharmacy, Professional Staff Development Program, Columbus, OH, US|USA. (September 1993)

"AIDS Update: Treatment and Legalities." Presented at 7th Annual; Critical Care Nursing: Quest for Excellence, Columbus, OH, US|USA. (September 1993)

"Update on Tuberculosis." Presented at Internal Medicine Grand Rounds, The Ohio State University, Columbus, OH, US|USA. (January 1993)

"Update on Infectious Diseases." Presented at Department of Physical Medicine and Rehabilitation Grand Rounds, Columbus, OH, US|USA. (May 1993)

"Azithromycin as Treatment for Disseminated MAC: Results of Monotherapy Trials." Presented at 17th AIDS Clinical Trials Group Meeting, Washington, DC, US|USA. (December 1993)

"Emerging Problems with Resistant Candida Species." Presented at 16th AIDS Clinical Trials Group Meeting, Washington, DC, US|USA. (February 1993)

"Immunizations of Interest to Military Personnel." Presented at Eighth Annual Ohio Army National Guard AMEDD Conference, Columbus, OH, US|USA. (April 1994)

"Tuberculosis in the 1990’s." Presented at Seventh Annual Update in Internal Medicine, Columbus, OH, US|USA. (September 1994)

"Mycobacterium avium Complex: Therapeutic Options." Presented at Exploring Controversial Issues in the Management of Infectious Diseases, Orlando, FL, US|USA. (October 1994)

"Management of Opportunistic Infections in AIDS." Presented at CME Meeting, Lincoln Park Area Physicians and Staff, Chicago, IL, US|USA. (November 1995)

"Tuberculosis Update." Presented at Ohio Medical Education Network, OMEN, Columbus, OH, US|USA. (April 1995)

"Tuberculosis of the Central Nervous System." Presented at Neurology Grand Rounds, Columbus, OH, US|USA. (October 1995)

"Current Treatment of Fungal Infections." Presented at Eighth Annual Update in Internal Medicine, Columbus, OH, US|USA. (October 1995)

"HIV Update." Presented at Medical Grand Rounds, Columbus, OH, US|USA. (October 1996)

"Cardiovascular Infections and Infections Associated with Cardiothoracic Surgeries." Presented at The 5th Annual Cardiovascular Diseases Symposium: The High Risk Patient - An Interspecialty Approach, Snowmass, CO, US|USA. (March 1996)

"Azithromycin Treatment Trials." Presented at Advances in the Prophylaxis and Management of MAC, Council on MAC Investigative Research, San Diego, CA, US|USA. (March 1996)

"AIDS Update: Focus on Occupational Risks." Presented at The 5th Annual Cardiovascular Diseases Symposium: The High Risk Patient - An Interspecialty Approach, Snowmass, CO, US|USA. (March 1996)

"Infectious Diseases Potpourri: Changing Trends, New Treatments." Presented at MedOhio Monthly CME Series, Columbus, OH, US|USA. (February 1996)

"Current Treatment for Fungal Infections: Dermatophytoses, Urinary Tract Infections, and Candidemia." Presented at The Manchester VA Medical Center Grand Rounds, Manchester, NH, US|USA. (February 1996)

"Central Nervous System Infections." Presented at Neurology for the Non-Neurologist CME Conference, Columbus, OH, US|USA. (May 1996)

"Infections in the Immunocompromised Host." Presented at Emergency Medicine Rounds, Columbus, OH, US|USA. (December 1996)

"Impact of Discontinuing PCP Prophylaxis in Subjects Receiving Antiretroviral Therapies Who Have Had Increases in CD4 Counts to >200 Cells/mm3." Presented at Twenty-second AIDS Clinical Trials Group Meeting, Washington, DC, US|USA. (December 1996)

"Case Studies in the Prophylaxis of MAC." Presented at Advisory Panel Program for the Management of Opportunistic Infections in the Patient with HIV: Balancing Quality and Cost, New York, NY, US|USA. (June 1997)

"Update on Prophylaxis and Treatment of Mycobacterium avium Complex." Presented at Opportunistic Infections Challenge Program, Washington, DC, US|USA. (November 1997)

"Medical Update." Presented at EMPOWERMENT State-Wide Conference for Women Living with HIV/AIDS, Columbus, OH, US|USA. (November 1997)

"Effective Treatment for Fungal Infections in HIV-Infected Patients." Presented at Opportunistic Infections Challenge Program, Philadelphia, PA, US|USA. (November 1997)

"AIDS Update." Presented at 119th Ohio Pharmacists Association Annual Conference, Columbus, OH, US|USA. (April 1997)

"AIDS Update ‘97: Opportunistic Infections." Presented at Ohio Medical Education Network (OMEN), Columbus, OH, US|USA. (March 1997)

"An Update on HIV Infection." Presented at Department of Medicine Grand Rounds, Columbus, OH, US|USA. (August 1997)

"Opportunistic Infections in AIDS Patients." Presented at 5th International Conference on the Prevention of Infection Symposium, Nice, FR|FRA. (May 1998)

"Nosocomial Candida Infections." Presented at The Association for Professionals in Infection Control and Epidemiology’s 25th Annual Educational Conference and International Meeting, San Diego, CA, US|USA. (May 1998)

"HIV Infection in Women." Presented at HIV Conference, Columbus, OH, US|USA. (October 1998)

"Treatment of Pneumocystis carinii Pneumonia." Presented at Intravenous Nurses Society Annual Meeting, Minneapolis, MN, US|USA. (May 2000)

"Immunization Update." Presented at Ohio Medical Education Network (OMEN),, Columbus, OH, US|USA. (April 2000)

"Issues Affecting Women with HIV/AIDS." Presented at The Ohio AIDS Coalition and The Ohio Department of Health Leadership 2000 Conference, Columbus, OH, US|USA. (May 2000)

"Immune Reconstitution in the Current Era of AIDS Care." Presented at Community Advisory Board Forum, Columbus, OH, US|USA. (November 2000)

"HIV/AIDS Update." Presented at Fairfield Medical Center, Lancaster, OH, US|USA. (March 2000)

"Complications of HIV Infection and HIV Therapies." Presented at Weekly HIV Conference, Division of HIV Medicine, Torrance, CA, US|USA. (July 2001)

"Fungal Infections: A Case-Based Assessment." Presented at Ohio Medical Education Network (OMEN), Columbus, OH, US|USA. (March 2001)

"AIDS Update." Presented at Ohio Medical Education Network (OMEN), Columbus, OH, US|USA. (January 2003)

"The Range of Immune Recovery Responses." Presented at Infectious Diseases Noon Conference, Rochester, NY, US|USA. (May 2003)

"Evolving Treatment Strategies in HIV Infection." Presented at 2004 Ohio AIDS Coalition/Ohio Department of Health Leadership Conference, Columbus, OH, US|USA. (April 2004)

"HIV Treatment Update: The Next Generation." Presented at 2005 Ohio AIDS Coalition/Ohio Department of Health Leadership Conference, Columbus, OH, US|USA. (April 2005)

"AIDS Update 2005." Presented at OSU MedNet 21 Program, Columbus, OH, US|USA. (October 2005)

"A5082: A Randomize, Double-Blind, Placebo-Controlled Study of Metformin and Rosiglitazone Alone or in Combination, in HIV-Infected Subjects with Hyperinsulinemia and Elevated Waist/Hip Ratio." Presented at ACTG National Meeting, Baltimore, MD, US|USA. (December 2005)

"Things We All Should Know About HIV/AIDS." Presented at Internal Medicine Grand Rounds, Columbus, OH, US|USA. (November 2006)

"HIV Update – What Internists Should Know about HIV/AIDS." Presented at Internal Medicine Grand Rounds, Jacksonville, FL, US|USA. (January 2007)

"HIV Issues in Primary Care Medicine." Presented at Annual Infectious Diseases CME Course, Columbus, OH, US|USA. (September 2007)

"Advances in the Diagnosis and Management of HIV/AIDS." Presented at The UN: Uniting the World Against AIDS, United Nations Day Conference, Columbus, OH, US|USA. (October 2007)

"Treating HIV in Older Adults." Presented at Topics in Geriatric Medicine Lecture Series, Cleveland, OH, US|USA. (May 2007)

"HIV/AIDS Update: Serving Underserved Populations." Presented at 9th Annual Ohio Free Clinics Conference, Columbus, OH. (October 2008)

"Use of Newer Vaccines in Healthy and Immunocompromised Adults." Presented at Infectious Diseases Update 2009, Columbus, OH, US|USA. (November 2009)

"Update from the XVIII International AIDS Conference." Presented at AETC Conference, Columbus, OH, US|USA. (October 2010)

"Managing HIV Co-Infections and Co-Morbidities: A Case-Based Panel Discussion." Presented at 2010 IAS-USA Fall Course: Improving the Management of HIV Disease, New York, NY, US|USA. (October 2010)

"HIV Infection – An Important Issue in Women’s Health." Presented at Center for Women’s Health CME Event., Columbus, OH, US|USA. (October 2010)

 

Professional Activities

present "The Suprising Region Where HIV is on the Rise". Yahoo! Health - Online audience 12.4 million. Columbus, OH.
present Publications Committee. Infectious Diseases Society of America. Arlington, VA.
2010 - present Writing Committee for the IDSA In Training Exam. Infectious Diseases Society of America.
2011 - present Infectious Diseases Society of America.
2009 - 2011 Reviewer. California HIV Research Program Study Section.